Sarah R. DiNapoli

Also affiliated with Johns Hopkins University, Lustgarten Foundation, Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Targeting a neoantigen derived from a common TP53 mutation”.

Targeting a neoantigen derived from a common TP53 mutation

Science(2021)10.1126/science.abc8697

N/A

0DataRank · unranked

350 citations

Katharine M. Wright, Jacqueline Douglass, Michael S. Hwang, Brian J. Mog, Alexander H. Pearlman +20 more

Targeting loss of heterozygosity for cancer-specific immunotherapy

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2022410118

N/A

0DataRank · unranked

75 citations

Brian J. Mog, Jacqueline Douglass, Alexander H. Pearlman, Emily Han-Chung Hsiue, Suman Paul +10 more

TCR β chain–directed bispecific antibodies for the treatment of T cell cancers

Science Translational Medicine(2021)10.1126/scitranslmed.abd3595

N/A

0DataRank · unranked

57 citations

Alexander H. Pearlman, Jacqueline Douglass, Brian J. Mog, Emily Han-Chung Hsiue, Michael S. Hwang +15 more

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens

Nature Communications(2021)10.1038/s41467-021-25605-4

N/A

0DataRank · unranked

39 citations

Michelle S. Miller, Puchong Thirawatananond, Jacqueline Douglass, Katharine M. Wright, Emily Han-Chung Hsiue +17 more

Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen

Nature Communications(2023)10.1038/s41467-023-40821-w

N/A

0DataRank · unranked

25 citations

Sarah R. DiNapoli, Michelle S. Miller, P. Aitana Azurmendi, Xiaowei Zhao, Zhiheng Yu +17 more

TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers

Nature(2024)10.1038/s41586-024-07233-2

N/A

0DataRank · unranked

44 citations

Jiaxin Ge, Brian J. Mog, Bum Seok Lee, Alexander H. Pearlman, Michael S. Hwang +22 more

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities

Science Translational Medicine(2024)10.1126/scitranslmed.adg7123

N/A

0DataRank · unranked

25 citations

Nikita Marcou, Sarah R. DiNapoli, Alexander H. Pearlman, Tushar D. Nichakawade, Michael S. Hwang +19 more

TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancers

Nature Cancer(2025)10.1038/s43018-025-01069-z

N/A

0DataRank · unranked

2 citations

Joshua Urban, Sarah R. DiNapoli, Bum Seok Lee, Taha Ahmedna, Tushar D. Nichakawade +26 more

Precision targeting of autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cells

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.19.682634

N/A

0DataRank · unranked

5 citations

Yuanxuan Xia, Brian J. Mog, Colin Gliech, Elana Shaw, Dylan P. Ferris +25 more

Engineering immunotoxin-equipped effector cells and evaluation in primary human immune cells

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.64898/2025.12.09.691975

N/A

0DataRank · unranked

1 citations

Brian J. Mog, Michael S. Hwang, Jordina Rincón-Torroella, Sarah R. DiNapoli, Suman Paul +11 more